ORIGINAL RESEARCH
Published on 17 Sep 2025
Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target
doi 10.3389/fcell.2025.1585521
- 995 views
- Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
- Research Topics
- Metabolic Adaptations and Immune Evasion in Hematological Malignancies: Challenges and Opportunities
Metabolic Adaptations and Immune Evasion in Hematological Malignancies: Challenges and Opportunities
245
Total downloads
2,095
Total views and downloads
